From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
Professor, Department of Human Genetics, University of Chicago. Age: 38
October 1, 2013|
© MATTHEW GILSONGrowing up in the town of Beersheba in Israel, Yoav Gilad became restless when high school failed to challenge him. So, after testing out of his classes and graduating early, he started taking college courses at age 15, eventually matriculating at Ben-Gurion University his hometown, where he majored in molecular genetics and biochemistry. “I was fascinated by the contrast between the fact that so much is planned and programmed, but there’s also so much variability,” Gilad recalls.
Mandatory army service sidelined his college career for three years, but Gilad eventually returned to Ben-Gurion, where he got his first taste of laboratory research near the end of his undergraduate tenure. Gilad says he was captivated by the idea that through laboratory science he could potentially become the first person in the world to find the answers to age-old questions. “The charm of that really attracted me,” he says.
METHODS: Near the end of his army service, Gilad met geneticist Doron Lancet, who, as part of his reserve duty, occasionally lectured to troops about genetics and the origin of life. Three years later, when Gilad applied to graduate school at the Weizmann Institute of Science, he looked up Lancet, who not only remembered the young graduate, but offered him a lab rotation on the spot. “I accepted him gladly because he is so brilliant,” says Lancet. To support himself financially, Gilad worked as a dive instructor and played on the Israeli and German six-man indoor professional volleyball circuits. “It paid better than a graduate school stipend,” he says.
In Lancet’s lab, Gilad showed that humans have nearly twice as many pseudogenes—genes that have lost the ability to code proteins—for olfactory receptors as do some nonhuman primates, reflecting humans’ reduced dependence on olfaction.1 In subsequent research, he and Lancet speculated that the marginalization of olfaction in some primate species, concomitant with the evolution of color vision, paved the way for humans’ predominant reliance on their visual system, which includes three types of color receptors called cones.
RESULTS: Although Gilad secured a faculty position at the University of Chicago right out of graduate school, he jumped at the opportunity to first explore a new research direction as a postdoc. “I knew I could gamble, do something a little dangerous,” he says. He spent the next two years working in Kevin White’s lab at Yale University developing high-throughput multispecies DNA arrays. Using this new tool, Gilad identified, across several primate species, sets of genes whose expression appears to be driven by natural selection, suggesting that gene regulation can be an important driver of evolution.2 “Yoav is unbelievably good about treating evolution in a quantitative fashion—one of the world’s best,” says Lancet.
DISCUSSION: Now in his own lab in Chicago, Gilad studies the mechanisms underlying gene regulation variability. In collaboration with Jonathan Pritchard, now at Stanford University, Gilad pegged genetic variants that alter chromatin accessibility and transcription factor binding as key mechanisms by which genetic variation leads to differences in human gene expression.3 “Yoav’s really fearless in terms of pushing new technologies and building up data sets that combine multiple aspects of gene regulation,” says Pritchard.
Next up for Gilad: reprogramming induced pluripotent stem cells (iPSCs) in humans, chimpanzees, and rhesus macaques to become cardiomyocytes, hepatocytes, and motor neurons, thereby expanding his search for variation in gene regulation to whole new classes of cells to which he previously has not had access. “Now we’re not limited by cells we can get from a blood draw.” he says, “Rather, we are limited to cells that we can differentiate from the iPSCs.”
October 2, 2013
There's a typo in reference 2. I'll let you find it.
October 11, 2013
Marginalization of genes for olfaction in humans as a result of the conversion of some of them into pseudogenes and the increase of their visual acuity could be independent or dependent on each other. But this notion can be tried in case of dolphins where vision and olfaction have been reduced.